FDA Approved: AFINITOR DISPERZ — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for Afinitor Disperz (everolimus) from Novartis. This approval updates its pediatric dispersible formulation and indicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberous Sclerosis Complex-associated Renal Angiomyolipoma
• Tuberous Sclerosis Complex-associated Subependymal Giant Cell Astrocytoma

Drugs mentioned

• AFINITOR DISPERZ (everolimus)

Snippet

SUPPL AP for AFINITOR DISPERZ (EVEROLIMUS)